CJC-1295 with DAC
£35.59
CJC-1295 with DAC is a laboratory-engineered peptide developed to function as an extended-duration analogue of growth hormone–releasing hormone (GHRH). By incorporating a Drug Affinity Complex (DAC), this version is designed to remain active for a longer period than non-DAC variants, enabling researchers to examine prolonged hormonal signaling in experimental models. Due to this extended activity profile, CJC-1295 with DAC has become a widely studied compound in research related to endocrine signaling, metabolic function, and physiological recovery processes.
For Research Use Only
This product is supplied strictly for scientific research and laboratory experimentation. It is not intended for human consumption, clinical use, or any form of therapeutic application
Research Areas of Interest
Scientific research involving CJC-1295 with DAC has focused on several interconnected biological pathways, including:
Sustained Growth Hormone Release
Evaluated for its capacity to support extended, pulsatile GH secretion compared to short-acting GHRH analogues.
Metabolic Regulation Models
Studied in relation to glucose handling, lipid metabolism, and energy balance in controlled preclinical research settings.
Tissue Maintenance & Repair Pathways
Explored for its involvement in cellular recovery mechanisms and protein synthesis-related signaling.
Comparative Endocrine Research
Utilized to contrast with CJC-1295 without DAC, allowing assessment of how prolonged half-life influences receptor engagement and hormonal response duration.
Collectively, these research areas position CJC-1295 with DAC as a valuable tool for laboratory studies requiring extended GHRH activity.
Technical Information
- Peptide Name: CJC-1295 with Drug Affinity Complex (DAC)
- Also Known As: DAC-GRF (1–29), Modified GRF (1–29) with DAC
- Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
- Molecular Weight: Approximately 3,368 g/mol
- Amino Acid Sequence:
Tyr–Ala–Asp–Ala–Ile–Phe–Thr–Asn–Ser–Tyr–Arg–Lys–Val–Leu–Ala–Gly–Gln–Leu–Ser–Ala–Arg–Lys–Leu–Leu–Gln–Asp–Ile–Met–Ser–Arg–Gln–Gln–Gly–Glu
- CAS Registry Number: 863288-34-0
• Peptide Type: Synthetic GHRH analogue with half-life–extending DAC modification
Terms & Conditions
By purchasing products from Tested Peptides, you confirm that you have read, understood, and agreed to the terms below:
Ethical & transparent:
For Research Purposes Only
All products are supplied strictly for non-clinical, non-commercial laboratory research. They are not intended for use in food, cosmetics, pharmaceuticals, or any application involving living organisms.
No Human or Animal Use
These products are not approved for use in or on humans or animals and must not be ingested, injected, applied topically, or otherwise introduced into the body.
Next day Delivery (Uk):
Order by 2:30 PM (Mon–Fri) for fast next day delivery
Expert customer support & education:
Customer Responsibility
The buyer is solely responsible for ensuring proper handling, storage, and use in compliance with all applicable laws and regulations. Tested Peptides does not provide legal or regulatory advice beyond this disclaimer.
Limitation of Liability
Tested Peptides accepts no responsibility for misuse, mishandling, or use outside the intended research purpose, nor for any consequences resulting from such use. All purchases and usage are entirely at the buyer’s own risk.
Eligible Customers
Products are intended only for individuals or institutions with appropriate knowledge of laboratory research practices. No claims are made regarding suitability for any specific research outcome.
